Navigation Links
CTi’s Technology Highly Applicable in “Frack Water” and Waste Water Treatment
Date:7/11/2013

Chatsworth, California (PRWEB) July 11, 2013

Cavitation Technologies, Inc. announced today that the Company will commence trial testing of it’s Cavitation Electrocoagulation System with several “frack water” and wastewater treatment facilities within the U.S.

CTi’s Electrocoagulation System provides an innovative and efficient solution for the treatment of wastewater. More importantly, because of the system’s low electricity requirements and miniaturization of needed power supplies, the system can dramatically reduce operating costs compared to conventional wastewater treatment methods.

Roman Gordon, the company’s CTO, added, “Our Cavitation waste water system has demonstrated it can dramatically minimize the presence of heavy metals, oil emulsions, fats, grease, bacteria, viruses, and cysts in an environmentally sound and cost-effective manner. Our Cavitation technology and Electrocoagulaiton process provides the opportunity to maximize the beneficial re-use of resource materials, minimize transportation and disposal costs, as well as their associated liabilities.”

Additionally, Gordon noted that the potential applications of CTi’s system are infinite, as waste water treatment plays a vital role in food, beverage, pharmaceutical, pulp and paper, textiles, manufacturing, marine industry, mining process water, municipal water management, and automotive uses. The Company plans to begin utilizing the system in fiscal 2014 and will identify strategic partners accordingly.

About CTI
Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, robust devices and systems and develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algal oil extraction, alcoholic beverage enhancement and water treatment. As an add-on to existing neutralization systems, the company’s patented NanoReactor™ allows refiners to significantly reduce both processing costs and the environmental impact, while also increasing the yield. More information is available at http://www.ctinanotech.com/.

The foregoing press release may contain forward-looking statements, including statements regarding, among other things, about the expectation of CTI's future business. These forward-looking statements are based largely on the Company's expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward looking statements as a result of a variety of factors including, among others, the state of the economy, the competitive environment, and the Company's performance. In light of these risks and uncertainties there can be no assurances that the forward looking statements contained in this press release will in fact transpire or prove to be accurate.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10917760.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Desmet Ballestra Will Install CTI’s System at Edible Oil Refinery in Ecuador
2. PathoGenetix to Debut New Genotyping Technology for Rapid Strain Typing at IAFP
3. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
4. TriMix for Travel Now Available at KRS Global Biotechnology
5. Official Opening of UKs Biggest Bioethanol Plant Using Praj Technology
6. CEM Introduces New Breakthrough Technology for Microwave Peptide Synthesis
7. iBio Pharmaceutical Technology Embraced by the Government of Brazil
8. Vinno Technology Co. Ltd Announced a Winner of the Renowned Platinum A' Design Award
9. City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall
10. Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013
11. Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief ... ), Inc. has been selected for membership in ARCS Alumni Hall of ...
(Date:10/11/2017)... 2017  VMS BioMarketing, a leading provider of patient support ... Nurse Educator (CNE) network, which will launch this week. The ... health care professionals to enhance the patient care experience by ... other health care professionals to help women who have been ... ...
(Date:10/10/2017)... DIEGO, CALIF. (PRWEB) , ... October 10, 2017 , ... ... as part of its corporate rebranding initiative announced today. The bold new look ... its reach, as the company moves into a significant growth period. , It will ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):